Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20512258 | 0.86 | NPSR1 (0.51) | CYP19A1ATMLMNANPSR1ALDH1A1 | |
| SCHEMBL20512253 | 0.80 | ALDH1A1 (0.51) | EGFRERBB2LMNAALDH1A1KMT2A | |
| SCHEMBL28532222 | 0.78 | EGFR (0.51) | EGFRERBB2CYP19A1ATMLMNA | |
| SCHEMBL20512263 | 0.77 | KMT2A (0.56) | ALDH1A1KMT2AMEN1 | |
| SCHEMBL20512235 | 0.77 | CA1 (0.46) | CYP19A1LMNANPSR1ALDH1A1KMT2A | |
| SCHEMBL20512274 | 0.76 | CYP19A1 (0.43) | CYP19A1ATMLMNANPSR1ALDH1A1 | |
| SCHEMBL20512265 | 0.74 | ALDH1A1 (0.50) | LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL20512232 | 0.73 | ALDH1A1 (0.48) | LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL20512261 | 0.73 | CA12 (0.52) | CYP19A1ATMLMNANPSR1ALDH1A1 | |
| SCHEMBL2595657 | 0.71 | ALDH1A1 (0.66) | EGFRERBB2CYP19A1ATMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180354963-A1 | NOVEL LACTONES | PURDUE RESEARCH FOUNDATION (US) | 2018-12-13 | — | — | US | disclosed |
| US-10138252-B1 | Lactones | PURDUE RESEARCH FOUNDATION (US) | 2018-11-27 | — | — | US | disclosed |
| US-20180305371-A1 | NOVEL LACTONES | PURDUE RESEARCH FOUNDATION (US) | 2018-10-25 | — | — | US | disclosed |
| US-10087190-B1 | Lactones | PURDUE RESEARCH FOUNDATION (US) | 2018-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180354963-A1 | NOVEL LACTONES | DHPS, FDPS, LSS | EGFR 3801/4885ERBB2 2288/4885CYP19A1 1049/4885 |
| US-20180305371-A1 | NOVEL LACTONES | DHPS, FDPS, LSS | EGFR 3801/4885ERBB2 2288/4885CYP19A1 1049/4885 |
| US-10138252-B1 | Lactones | DHPS, FDPS, LSS | EGFR 3572/4885ERBB2 2159/4885CYP19A1 850/4885 |
| US-10087190-B1 | Lactones | DHPS, FDPS, LSS | EGFR 3572/4885ERBB2 2159/4885CYP19A1 850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.